Delivery Order SPE2DB22D1017-SPE2DB25FF4RB
Award Date
2/3/25
Potential Completion Date
2/4/25
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XHANCE 93 MCG nasal spray. The firm-fixed-price contract, valued at $7,435.60, has a period of performance through February 14, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products including the medication XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a ceiling value of $1,144.68 and a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a ceiling value of $1,026.39 and a period of performance through April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to deliver...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the pharmaceutical product XHANCE 93 MCG NASAL SPRAY 16ML. The firm-fixed-price contract has a ceiling value of $1,222.86 and a period of performance through July 14, 2023. There is no set-aside designation on this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA...
This is a $3,783.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the medical product "XHANCE 93 MCG NASAL SPRAY 16ML" and has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary...
This federal contract award is for the delivery of XHANCE 93 MCG nasal spray 16ML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract has a firm fixed price pricing type and a potential value of $3,963.75. The contract has a completion date of February 29, 2024. Amerisourcebergen Drug Corp holds an Indefinite...
This federal contract award, with ID SPE2DB20D2104|SPE2DB24FMASB, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,313.67 Firm Fixed Price contract is for the delivery of XHANCE 93 MCG Nasal Spray 16ML, with a completion date of September 4, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November...
This federal contract award is a delivery order valued at $1,212.30, awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product. The contract is a firm fixed-price arrangement with a period of performance through February 4, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award is for pharmaceutical products and medical supplies provided by AmerisourceBergen Drug Corporation to the U.S. government. The award is a $1,708.18 delivery order (SPE2DX15D3504 | SPE2DX24F09L5) under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of medical commodities, including prescription...
This federal contract award, with ID SPE2DX15D3202|SPE2DX24F2NH2, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML to the Defense Logistics Agency (DLA) Troop Support Medical, which is a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through its Corporate Office division. The contract has a ceiling value of $1,604.65 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp...